(FIE) Fielmann Aktiengesellschaft - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0005772206

FIE: Glasses, Frames, Lenses, Sunglasses, Hearing Aids

Fielmann Group AG stands as a leader in the optical and hearing aid sectors across Europe, operating in Germany, Switzerland, Austria, and beyond. Their comprehensive product line includes eyewear, contact lenses, sunglasses, and hearing aids, all under well-known brands such as fielmann and Optika Clarus. This diversification not only broadens their market reach but also strengthens their position in the health care equipment industry.

The companys distribution strategy is a blend of modern and traditional, utilizing retail stores, their e-commerce platform, and partnerships to ensure wide accessibility. This multi-channel approach caters to a broad customer base, enhancing their competitive edge in a rapidly evolving market. Notably, Fielmann Group AG is a subsidiary of Korva SE, underscoring its robust corporate structure.

Financially, Fielmann Group AG presents an intriguing profile with a market capitalization of 3657.92M EUR. The trailing P/E ratio of 26.08 and forward P/E of 16.53 suggest expectations of future growth. The price-to-book ratio of 3.78 indicates a premium, reflecting investor confidence in their intangible assets and brand value. The price-to-sales ratio of 1.70 aligns with industry peers, indicating efficient sales performance.

Investors should consider Fielmanns vertically integrated model, which streamlines production and distribution, potentially boosting margins. Their expansion into hearing aids taps into a growing market, driven by an aging population and increased health awareness. With a focus on innovation, Fielmann is well-positioned to capitalize on rising demand in both optics and audiology, making them a compelling option for those seeking exposure to the health care equipment sector.

Additional Sources for FIE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

FIE Stock Overview

Market Cap in USD 3,860m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Health Care Equipment
IPO / Inception

FIE Stock Ratings

Growth Rating -32.6
Fundamental 70.5
Dividend Rating 7.30
Rel. Strength 7.19
Analysts -
Fair Price Momentum 39.85 EUR
Fair Price DCF 51.29 EUR

FIE Dividends

Dividend Yield 12m 2.33%
Yield on Cost 5y 1.88%
Annual Growth 5y -12.50%
Payout Consistency 93.9%

FIE Growth Ratios

Growth Correlation 3m 0.7%
Growth Correlation 12m -14.5%
Growth Correlation 5y -66.8%
CAGR 5y -3.88%
CAGR/Max DD 5y -0.07
Sharpe Ratio 12m -0.18
Alpha -1.75
Beta 0.420
Volatility 26.59%
Current Volume 22.5k
Average Volume 20d 29.4k
What is the price of FIE stocks?
As of April 19, 2025, the stock is trading at EUR 43.55 with a total of 22,454 shares traded.
Over the past week, the price has changed by +4.69%, over one month by -0.34%, over three months by +8.06% and over the past year by +6.60%.
Is Fielmann Aktiengesellschaft a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Fielmann Aktiengesellschaft (XETRA:FIE) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.50 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FIE as of April 2025 is 39.85. This means that FIE is currently overvalued and has a potential downside of -8.5%.
Is FIE a buy, sell or hold?
Fielmann Aktiengesellschaft has no consensus analysts rating.
What are the forecast for FIE stock price target?
According to ValueRays Forecast Model, FIE Fielmann Aktiengesellschaft will be worth about 43.4 in April 2026. The stock is currently trading at 43.55. This means that the stock has a potential downside of -0.28%.
Issuer Forecast Upside
Wallstreet Target Price 55.9 28.3%
Analysts Target Price - -
ValueRay Target Price 43.4 -0.3%